![]() 3-(Trifluoromethyl)benzyl chloride structure
|
Common Name | 3-(Trifluoromethyl)benzyl chloride | ||
---|---|---|---|---|
CAS Number | 705-29-3 | Molecular Weight | 194.581 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 179.1±35.0 °C at 760 mmHg | |
Molecular Formula | C8H6ClF3 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 48.9±0.0 °C | |
Symbol |
![]() ![]() GHS02, GHS05 |
Signal Word | Danger |
Name | 3-Chloromethyl-benzotrifluoride |
---|---|
Synonym | More Synonyms |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 179.1±35.0 °C at 760 mmHg |
Molecular Formula | C8H6ClF3 |
Molecular Weight | 194.581 |
Flash Point | 48.9±0.0 °C |
Exact Mass | 194.011017 |
LogP | 3.06 |
Vapour Pressure | 1.3±0.3 mmHg at 25°C |
Index of Refraction | 1.457 |
Storage condition | Flammables area |
Symbol |
![]() ![]() GHS02, GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H226-H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
Personal Protective Equipment | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
Hazard Codes | C:Corrosive; |
Risk Phrases | R10;R34 |
Safety Phrases | S16-S26-S36/37/39-S45 |
RIDADR | UN 2920 8/PG 2 |
WGK Germany | 3 |
Packaging Group | III |
Hazard Class | 8 |
HS Code | 29036990 |
~% 3-(Trifluoromet... CAS#:705-29-3 |
Literature: Helvetica Chimica Acta, , vol. 54, p. 868 - 897 Journal of Organic Chemistry, , vol. 42, # 5 p. 868 - 871 |
~% 3-(Trifluoromet... CAS#:705-29-3 |
Literature: Journal of Medicinal Chemistry, , vol. 42, # 6 p. 1007 - 1017 |
~% 3-(Trifluoromet... CAS#:705-29-3 |
Literature: Helvetica Chimica Acta, , vol. 54, p. 868 - 897 Journal of Organic Chemistry, , vol. 42, # 5 p. 868 - 871 |
Precursor 3 | |
---|---|
DownStream 8 | |
HS Code | 2903999090 |
---|---|
Summary | 2903999090 halogenated derivatives of aromatic hydrocarbons VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound.
J. Comb. Chem. 11(1) , 34-43, (2009) For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducib... |
|
Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.
J. Comb. Chem. 11 , 14-33, (2009) Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa... |
|
Synthesis and biological evaluation of a series of dithiocarbamates as new cholinesterase inhibitors.
Arch. Pharm. (Weinheim) 346(8) , 571-6, (2013) In the present paper, a novel series of dithiocarbamates was synthesized via the treatment of 4-(trifluoromethyl)benzyl chloride with appropriate sodium salts of N,N-disubstituted dithiocarbamic acids... |
m-(Trifluoromethyl)benzyl Chloride |
EINECS 211-884-4 |
1-(Chloromethyl)-3-(trifluoromethyl)benzene |
3-(Trifluoromethyl)benzyl chloride |
Benzene, 1-(chloromethyl)-3-(trifluoromethyl)- |
α'-Chloro-α,α,α-trifluoro-m-xylene |
m-Xylene, α'-chloro-α,α,α-trifluoro- |
MFCD00000908 |